At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Apr 17, 2026 at 08:30 ET
Royalty Pharma announced a quarterly dividend of $0.235 per share, payable June 10, 2026, to shareholders of record as of May 15, 2026. This is a routine capital return with no change in dividend policy or magnitude.
- Royalty Pharma declared a quarterly dividend of $0.235 per Class A ordinary share.
- Dividend payable on June 10, 2026, to shareholders of record on May 15, 2026.
- No change in dividend amount or policy announced.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access